Blog
RSS FeedPosted by Michael Wonder on 17 Jan 2020
Defining the concept of fair pricing for medicines
13 January 2020 - Suerie Moon and colleagues consider what makes a fair price for both buyers and sellers. ...
Posted by Michael Wonder on 12 Jan 2020
The Tories must learn from the Orkambi victory and keep drug-pricing off the table
12 January 2020 - To match its rhetoric on the NHS, the government has to legally commit to preventing drug-pricing being ...
Posted by Michael Wonder on 10 Dec 2019
Biotech companies defend prices of one-off gene therapy
9 December 2019 - Latest treatments with price tags as high as $2 million require new financing models. ...
Posted by Michael Wonder on 05 Dec 2019
Is it time to look beyond price with biosimilars?
5 December 2019 - While there is no question that falling prices that come with competition are cause for optimism in ...
Posted by Michael Wonder on 30 Nov 2019
NHS and drug prices could be included in US-UK trade deal, leaked documents suggest
27 November 2019 - The NHS and drug patents have been part of ongoing post-Brexit trade negotiations between the US ...
Posted by Michael Wonder on 16 Nov 2019
Labour will exclude the NHS and medicines from trade deals with the US
17 November 2019 - Donald Trump wants the big US pharmaceutical companies to get its hands on our public services – ...
Posted by Michael Wonder on 07 Nov 2019
Paying £500 million more a week for drugs post-Brexit is based on a fairly extreme scenario
7 November 2019 - The UK could pay £500 million more per week for drugs following a post-Brexit trade deal with ...
Posted by Michael Wonder on 07 Nov 2019
Brexit: what it could mean for drug prices
5 November 2019 - Trading away the UK’s rights to drive down drug prices could cost the NHS half a ...
Posted by Michael Wonder on 06 Nov 2019
Corbyn accuses Tories of planning deal to hike drug prices with Trump as election looms
5 November 2019 - Drug prices have become an issue in the UK’s general election, after Labour leader Jeremy Corbyn ...
Posted by Michael Wonder on 29 Oct 2019
NHS bill for US drugs 'could soar under post-Brexit trade deal'
28 October 2019 - Dispatches investigation finds 'drug pricing' has been discussed in six initial meetings between trade officials from the ...
Posted by Michael Wonder on 29 Oct 2019
UK officials discussed NHS at ‘secret’ meetings with US drug companies as part of trade talks
29 October 2019 - Envoys sidestep ban on discussing drug prices by referring to controversial subject ‘valuing innovation’. ...
Posted by Michael Wonder on 05 Oct 2019
Drug pricing: Could Labour’s “radical” plan work?
4 October 2019 - A necessary reform or a threat to research? ...
Posted by Michael Wonder on 03 Oct 2019
Drug firms 'colluded' to overcharge NHS by up to 1,800%
3 October 2019 - Three drug manufactures broke competition law by colluding to illegally boost the price of a vital ...
Posted by Michael Wonder on 27 Sep 2019
Industry shoots down Labour's plans to tackle 'extortionate' drug prices
26 September 2019 - Labour's promise to “take on pharmaceutical companies” which “deny life-saving and life-changing medicines to ill patients ...
Posted by Michael Wonder on 22 Aug 2019
ABPI position on US trade deal and medicines pricing
21 August 2019 - In response to concerns about the impact a US trade deal would have on medicine pricing, ...